Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04216225 · ClinicalTrials.gov registry record
Pre-hospital Tourniquet in Extremity Injury
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 55
- Enrollment target
NCT04216225: Completed study, sponsored by Methodist Health System.
NCT04216225 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04216225 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
2.1. Objective: • Primary Objective: To compare outcomes of patients with extremity injuries presenting with or without pre-hospital tourniquet placement. 2.2. Study Outcome Measures * Primary Outcome: Incidence of arrival in shock (SBP \<90) * Secondary Outcomes: Demographics, comorbidities, mechanism of injury, cause of injury, diagnosis codes, procedure codes, Injury Severity Scale, Abbreviated Injury Scale, operative management vs. non-operative management, radiologic findings, pathologic findings, tourniquet effectiveness (as determined both subjectively by trauma surgeon and objectively by presence vs. absence of pulse below level of tourniquet application), total number of units of blood products transfused within first 24 hrs, total number of units of blood products for index admission, type of blood products or other fluid given, hospital length of stay, ICU length of stay, ventilator days, infectious complications, other complications, discharge disposition, 24 hr mortality, overall mortality.
Primary Outcome
(Systolic Blood Pressure \<90 mmHg (Millimeter of mercury))
Interventions
- OTHER pre-hospital tourniquet placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2021-12-13 |
What the finished NCT04216225 record still lists
NCT04216225 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which pre-hospital tourniquet placement is the first listed.
NCT04216225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04216225 about?
NCT04216225 is a clinical study titled "Pre-hospital Tourniquet in Extremity Injury". 2.1. Objective: • Primary Objective: To compare outcomes of patients with extremity injuries presenting with or without pre-hospital tourniquet placement. 2.2. Study Outcome Measures * Primary Outcome: Incidence of arrival in shock (SBP \<90) * Secondary Outcomes: Demographics, comorbidities, mec...
What is the current status of trial NCT04216225?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2018-11-01. Estimated completion is 2021-12-13.
What interventions are being tested in trial NCT04216225?
The interventions under investigation include: pre-hospital tourniquet placement (OTHER).
Who is sponsoring clinical trial NCT04216225?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI